Yahoo Web Search

  1. KEYS, Bristol-Myers Squibb Co. BMY, NRG Energy Inc. NRG and Arconic Inc. ARNC. Wall Street just completed a disappointing August, which historically remains weak ...

  2. Bristol-Myers Squibb Company BMY suffered a setback as a late-stage study evaluating its blockbuster immuno-oncology drug Opdivo for the treatment of malignant brain tumor ...

  3. Stocks recently featured in the blog include: Allegiant Travel Co. ALGT, Bristol-Myers Squibb Co. BMY, NewMarket Corp. NEU, North American Construction Group ...

  4. Bristol-Myers Squibb Company BMY announced long-term pooled efficacy and safety results from the phase III CheckMate-017 and CheckMate-057 studies in patients with previously-treated ...

  5. Bristol-Myers Squibb Co said on Thursday its blockbuster cancer immunotherapy, Opdivo, failed to meet the main goal of a late-stage trial testing it in patients with ...

  6. Stocks recently featured in the blog include: Allergan AGN, Merck MRK and Roche RHHBY, J&J JNJ and Bristol-Myers BMY. This week, Allergan settled with two counties of Ohio for ...

  7. Bristol-Myers' Opdivo fails to meet goal of brain tumor study

    Reuters via Yahoo FinanceSep 05 11:09 AM

    Bristol-Myers Squibb Co said on Thursday its blockbuster cancer immunotherapy, Opdivo, failed to meet a main goal of a late-stage trial, testing it in patients with ...

  8. 2 Large-Cap Companies Declare Dividends

    GuruFocus.com via Yahoo FinanceSep 12 17:36 PM

    Shares of Bristol-Myers Squibb Co. (NYSE:BMY) rose 0.18% to $49.33 in extended trading on Wednesday after the drugmaker announced the quarterly dividend. On Nov. ...

  9. NYSE: WST) Adamis Pharmaceuticals Corp (NASDAQ: ADMP) Aerie Pharmaceuticals Inc (NASDAQ: AERI)(announced $250 million worth of convertible senior note offering) AngioDynamics, Inc. NASDAQ: ANGO ...

  10. Merck, Pfizer Slide on Pelosi’s ‘Scary’ Drug-Pricing Plan

    Bloomberg via Yahoo FinanceSep 10 14:00 PM

    Drugmakers from Merck & Co. to Pfizer Inc. were under pressure in Tuesday's trading after documents showed House leader Nancy Pelosi's drug pricing plan appears skewed “to the more aggressive ...

  1. Ads
    related to Bristol-Myers Squibb Co